Lynn Healey
About Lynn Healey
Lynn Healey Chief Financial Officer at Sequence Bio
Lynn Healey joined Sequence Bio as Chief Financial Officer in April 2021. In this role, she managed the company's financial strategy, overseeing budgeting, forecasting, and financial reporting. Her leadership in financial operations was a critical component of the company’s growth and organizational stability. Under her guidance, Sequence Bio improved its financial performance and navigated complex financial landscapes.
Lynn Healey Appointed Chief Executive Officer at Sequence Bio
In September 2023, Lynn Healey was appointed as the Chief Executive Officer of Sequence Bio. Her transition to CEO marked a significant leadership change for the company. As CEO, Healey focuses on driving the company’s strategic vision and operational execution, aiming to enhance innovation, growth, and market positioning. Her previous experience as CFO provides a strong financial foundation to lead Sequence Bio towards its future objectives.